How a Diabetes Rx Saved Lives
A common diabetes medication may be helping patients' tickers, too.
Have Diabetes, Will Exercise
Exercise may be at the heart of good diabetes control. Literally.
Sugar Nation: Diabetes and Prediabetes in the US
Diabetes is a major cause of illness and death in the US. But there may be some hope on that front.
For Diabetes, Surgery May Have Better Outcomes
For the growing number of type 2 diabetes patients in the US, standard medical treatments might not be the only effective option.
Atrial Fibrillation: What Women Need to Know
Heart rhythm disorders affect more than 2 million Americans. The most common of these disorders is atrial fibrillation (AFib) — and it may affect women differently than men.
Rx Shows Promise for Diabetes Patients
Diabetes patients often face a second problem: kidney disease. But a new medication may be here to help.
Joint Pain Warning for Diabetes Meds
The U.S. Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain that can be severe and disabling.
New Diabetes Combo Rx Gets Go-Ahead
The FDA approval of a new combination medication should soon bring type 2 diabetes patients a new treatment option.
FDA Approves New Diabetes Combo Rx
RIDGEFIELD, Conn. and INDIANAPOLIS, Aug. 27, 2015 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Synjardy® (empagliflozin and metformin hydrochloride) tablets, from Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY), for the treatment of adults with type 2 diabetes (T2D).
Popular Diabetes Rx May Have New Destination in the Body
A new form of a popular medication might change the game for some patients with type 2 diabetes.